Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model.
Neuropsychopharmacology
; 47(9): 1733, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35701551
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Neuropsychopharmacology
Journal subject:
NEUROLOGIA
/
PSICOFARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
United States